Renu Wadhwa Selected Research

Renu Wadhwa Research Topics

Disease

85	Neoplasms (Cancer) 10/2022 - 08/2002
22	Neoplasm Metastasis (Metastasis) 02/2022 - 01/2004
16	Carcinogenesis 02/2021 - 01/2005
8	Breast Neoplasms (Breast Cancer) 06/2021 - 06/2006
7	Glioma (Gliomas) 02/2020 - 09/2009
6	AIDS-Related Complex (ARC) 01/2022 - 11/2013
5	Neuroblastoma 02/2020 - 01/2012
4	Hypoxia (Hypoxemia) 12/2021 - 01/2018
4	Parkinson Disease (Parkinson's Disease) 10/2021 - 07/2006
4	Inflammation (Inflammations) 09/2020 - 01/2012
4	Neurodegenerative Diseases (Neurodegenerative Disease) 09/2020 - 01/2011
3	Amnesia (Dissociative Amnesia) 07/2016 - 01/2011
2	Urticaria (Hives) 12/2021 - 07/2021
2	Cognitive Dysfunction 07/2021 - 09/2019
2	Uterine Cervical Neoplasms (Cancer of the Cervix) 05/2020 - 12/2019
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2020 - 01/2018
2	Liver Cirrhosis (Hepatic Cirrhosis) 10/2019 - 07/2015
2	Memory Disorders (Memory Loss) 09/2019 - 01/2011
2	Melanoma (Melanoma, Malignant) 01/2019 - 07/2016
2	Keloid 10/2017 - 07/2016
2	Fibrosis (Cirrhosis) 10/2017 - 07/2015
2	Brain Diseases (Brain Disorder) 07/2016 - 01/2013
2	Glioblastoma (Glioblastoma Multiforme) 11/2010 - 09/2009
1	COVID-19 08/2021
1	Lung Neoplasms (Lung Cancer) 01/2021
1	Gliosis 09/2020
1	Neuroinflammatory Diseases 09/2020

Drug/Important Bio-Agent (IBA)

42	Proteins (Proteins, Gene)FDA Link 10/2022 - 09/2002
37	mortalinIBA 02/2021 - 06/2003
21	AshwagandhaIBA 10/2022 - 04/2007
14	withanoneIBA 01/2022 - 04/2008
9	withaferin AIBA 01/2022 - 09/2009
9	Pharmaceutical PreparationsIBA 12/2021 - 07/2007
9	Small Interfering RNA (siRNA)IBA 05/2018 - 10/2005
8	caffeic acid phenethyl esterIBA 01/2022 - 01/2018
8	Heterogeneous-Nuclear Ribonucleoprotein KIBA 01/2020 - 05/2007
7	Telomerase (Telomerase Reverse Transcriptase)IBA 01/2021 - 08/2002
7	Catalytic RNA (Ribozymes)IBA 01/2012 - 06/2003
6	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 02/2022 - 10/2014
5	WithanolidesIBA 10/2022 - 12/2014
5	PhytochemicalsIBA 01/2020 - 10/2009
5	Heat-Shock Proteins (Heat-Shock Protein)IBA 03/2019 - 01/2005
4	CateninsIBA 02/2022 - 05/2018
4	Propolis (Bee Bread)IBA 12/2021 - 03/2018
4	Tumor Suppressor Protein p53IBA 12/2021 - 01/2009
4	Indicators and Reagents (Reagents)IBA 02/2020 - 10/2010
4	Scopolamine (Hyoscine)FDA Link 09/2019 - 01/2011
4	MKT 077IBA 01/2017 - 08/2002
4	Tumor Suppressor Proteins (Proteins, Tumor Suppressor)IBA 01/2016 - 10/2011
4	glucose-regulated proteinsIBA 03/2015 - 01/2005
3	Matrix Metalloproteinases (MMPs)IBA 02/2022 - 10/2014
3	VimentinIBA 02/2022 - 11/2019
3	artepillin CIBA 01/2022 - 07/2021
3	MetalsIBA 12/2021 - 02/2020
3	EnzymesIBA 12/2021 - 04/2004
3	MicroRNAs (MicroRNA)IBA 01/2021 - 10/2011
3	triethylene glycolIBA 07/2020 - 01/2017
3	Fibronectins (Fibronectin)IBA 01/2020 - 12/2004
3	Cyclin-Dependent Kinase Inhibitor p16IBA 06/2015 - 09/2002
3	Coloring Agents (Dyes)IBA 03/2012 - 08/2002
2	Messenger RNA (mRNA)IBA 10/2022 - 10/2011
2	Complementary DNA (cDNA)IBA 02/2022 - 01/2016
2	Cadherins (E-Cadherin)IBA 02/2022 - 11/2019
2	AntioxidantsIBA 07/2021 - 01/2012
2	PolymersIBA 06/2021 - 11/2007
2	Adenosine Triphosphate (ATP)IBA 06/2021 - 12/2019
2	Apoptosis Regulatory ProteinsIBA 08/2020 - 01/2019
2	cucurbitacin BIBA 01/2020 - 01/2018
2	Cyclin DIBA 01/2020 - 01/2019
2	Carotenoids (Carotene)IBA 06/2019 - 03/2019
2	fucoxanthinIBA 06/2019 - 03/2019
2	HSP70 Heat-Shock Proteins (Heat-Shock Protein 70)IBA 10/2017 - 03/2015
2	Cholinergic Agents (Cholinergics)IBA 07/2016 - 01/2011
2	embelinIBA 01/2015 - 10/2014
2	Glutamic Acid (Glutamate)FDA Link 11/2013 - 01/2012
2	AntibodiesIBA 05/2013 - 05/2007
2	Cyclin D1IBA 01/2013 - 01/2013
2	rhodacyanineIBA 03/2012 - 08/2002
2	DNA (Deoxyribonucleic Acid)IBA 07/2009 - 03/2007
2	Peptides (Polypeptides)IBA 05/2007 - 09/2004
1	Cell Surface ReceptorsIBA 10/2022
1	LigandsIBA 10/2022
1	Angiotensin-Converting Enzyme 2IBA 10/2022
1	Tight Junction ProteinsIBA 02/2022
1	ClaudinsIBA 02/2022
1	Lipid Bilayers (Lipid Bilayer)IBA 01/2022
1	PhosphatidylserinesIBA 01/2022
1	TubulinIBA 12/2021
1	LuciferasesIBA 12/2021
1	Phenobarbital (Luminal)FDA Link 06/2021
1	TriazolesIBA 02/2021
1	tetraethylpyrazine (TEP)IBA 01/2021
1	CyclinsIBA 08/2020
1	olaparibIBA 05/2020
1	Poly Adenosine Diphosphate RiboseIBA 05/2020
1	StilbenesIBA 02/2020
1	ResveratrolIBA 02/2020

Therapy/Procedure

25	Therapeutics 01/2021 - 01/2004
4	Quantum Dots (Quantum Dot) 11/2013 - 12/2003
3	Drug Therapy (Chemotherapy) 01/2018 - 10/2010